Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes. (Q38195530)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

review article

1 reference

title

Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Filip K Knop

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Morten Hansen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

1 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

published in

Current diabetes report

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

482

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json

Role of bile acids and bile acid receptors in metabolic regulation

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

A G protein-coupled receptor responsive to bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Bile acid sequestrants: more than simple resins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Absorption of colesevelam hydrochloride in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Colestipol at varying dosage intervals in the treatment of moderate hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Hypoglycemic effects of colestimide on type 2 diabetic patients with obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

AACE comprehensive diabetes management algorithm 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Major lipids, apolipoproteins, and risk of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Identification of a nuclear receptor for bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Bile acids: natural ligands for an orphan nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Endogenous bile acids are ligands for the nuclear receptor FXR/BAR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Bile salt transporters: molecular characterization, function, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Expression and function of the bile acid receptor TGR5 in Kupffer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Identification of membrane-type receptor for bile acids (M-BAR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Effect of cholestyramine on bile acid metabolism in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Plasma bile acids are not associated with energy metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Bile acid sequestration reduces plasma glucose levels in db/db mice by increasing its metabolic clearance rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

TGR5 potentiates GLP-1 secretion in response to anionic exchange resins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Colesevelam improves oral but not intravenous glucose tolerance by a mechanism independent of insulin sensitivity and β-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Bile acid binding resin improves metabolic control through the induction of energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Feeding rats diets containing cheno- or ursodeoxycholic acid or cholestyramine modifies intestinal uptake of glucose and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Colestyramine slows gastric emptying of liquids and reduces appetite in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0482-4

Drug interactions with colesevelam hydrochloride, a novel, potent lipid-lowering agent

21 January 2018

1 reference

12 December 2020

The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes

1 reference

12 December 2020

Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects

1 reference

12 December 2020

Chronic effect of oral cholestyramine, a bile salt sequestrant, and exogenous cholecystokinin on insulin release in rats

1 reference

12 December 2020

Absorption, distribution and excretion of GT31-104, a novel bile acid sequestrant, in rats and dogs after acute and subchronic administration

1 reference

12 December 2020

Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system.

1 reference

12 December 2020

Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group

1 reference

12 December 2020

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

1 reference

12 December 2020

Effect of cholestyramine on plasma cholecystokinin and pancreatic polypeptide levels, and exocrine pancreatic secretion

1 reference

12 December 2020

Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM

1 reference

12 December 2020

Colesevelam hydrochloride.

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

12 December 2020

Bile acid sequestrants improve glycemic control in type 2 diabetes: a proposed mechanism implicating glucagon-like peptide 1 release

1 reference

12 December 2020

Effects of colesevelam on LDL-C, A1c and GLP-1 levels in patients with type 1 diabetes: a pilot randomized double-blind trial

1 reference

12 December 2020

10.1007/S11892-014-0482-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 March 2020

1040124140

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24623198%20AND%20SRC:MED&resulttype=core&format=json